Skip to main content
SpringerLink
Log in

Memory impairment associated with varenicline

A case series from the New Zealand Intensive Medicines Monitoring Programme

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kunac DL, Harrison-Woolrych M, Tatley MV (2008) Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use. N Z Med J 121(1283):76–89

    PubMed  Google Scholar 

  2. World Health Organization–Uppsala Monitoring Centre. The use of the WHO–UMC system for standardised case causality assessment. Available at: http://who-umc.org/Graphics/24734.pdf. Accessed Nov 2012

  3. Harrison-Woolrych M, Ashton J (2011) Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand. Drug Saf 34(9):763–772

    Google Scholar 

  4. Harrison-Woolrych M, Maggo S, Tan M, Savage R, Ashton J (2011) Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand. Drug Saf 35(1):33–43

    Article  Google Scholar 

  5. Institute for Safe Medication Practices (ISMP) (2010) Varenicline (Chantix, Champix) update. ISMP QuarterWatch report Quarter 4, 2011

  6. Pfizer Ltd (2012) Summary of product characteristics and patient information leaflet for Champix. Available at: http://www.medicines.org.uk/EMC/searchresults.aspx?term=varenicline+tartrate&searchtype=QuickSearch. Accessed Nov 2012

  7. Pfizer New Zealand Ltd (2011) New Zealand data sheet for Champix. Available at: http://www.medsafe.govt.nz/profs/datasheets. Accessed June 2011

  8. Pfizer Ltd (2012) Chantix product labeling. Available at: http://www.pdr.net/drugpages/productlabeling.aspx?mpcode=62950550#section-9.2. Accessed Feb 2012

Download references

Author information

Authors and Affiliations

  1. Intensive Medicines Monitoring Programme, New Zealand Pharmacovigilance Centre, Department of Preventive and Social Medicine, University of Otago Medical School, PO Box 913, Dunedin, 9054, New Zealand

    Ming Tan & Mira Harrison-Woolrych

Authors
  1. Ming Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mira Harrison-Woolrych
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ming Tan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, M., Harrison-Woolrych, M. Memory impairment associated with varenicline. Eur J Clin Pharmacol 69, 1195–1196 (2013). https://doi.org/10.1007/s00228-012-1458-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-012-1458-4

Keywords

Search

Navigation